These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39068570)

  • 1. RNA Interference based Midkine Gene Therapy for Hepatocellular Carcinoma.
    Mamdouh S; Khorshed FEM; Hammad G; Magdy M; Abdelraouf A; Hemida E; Shemis M
    Asian Pac J Cancer Prev; 2024 Jul; 25(7):2371-2379. PubMed ID: 39068570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy.
    Gowhari Shabgah A; Ezzatifar F; Aravindhan S; Olegovna Zekiy A; Ahmadi M; Gheibihayat SM; Gholizadeh Navashenaq J
    IUBMB Life; 2021 Apr; 73(4):659-669. PubMed ID: 33625758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells.
    Zhong J; Huang HL; Li J; Qian FC; Li LQ; Niu PP; Dai LC
    Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):82-9. PubMed ID: 25655295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expression.
    Bie CQ; Liu XY; Cao MR; Huang QY; Tang HJ; Wang M; Cao GL; Yi TZ; Wu SL; Xu WJ; Tang SH
    Oncotarget; 2016 Nov; 7(48):79305-79318. PubMed ID: 27813495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients.
    El-Shayeb AF; El-Habachi NM; Mansour AR; Zaghloul MS
    Medicine (Baltimore); 2021 Apr; 100(17):e25112. PubMed ID: 33907088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.
    Zhu WW; Guo JJ; Guo L; Jia HL; Zhu M; Zhang JB; Loffredo CA; Forgues M; Huang H; Xing XJ; Ren N; Dong QZ; Zhou HJ; Ren ZG; Zhao NQ; Wang XW; Tang ZY; Qin LX; Ye QH
    Clin Cancer Res; 2013 Jul; 19(14):3944-54. PubMed ID: 23719264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism.
    Sureban SM; Madhoun MF; May R; Qu D; Ali N; Fazili J; Weygant N; Chandrakesan P; Ding K; Lightfoot SA; Houchen CW
    Oncotarget; 2015 Nov; 6(35):37200-15. PubMed ID: 26468984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker.
    Christou C; Stylianou A; Gkretsi V
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.
    Vongsuvanh R; van der Poorten D; Iseli T; Strasser SI; McCaughan GW; George J
    PLoS One; 2016; 11(5):e0155800. PubMed ID: 27219517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Prognostic Value of Talin-1 and Midkine as Tumor Markers in Hepatocellular Carcinoma in Egyptian Patients.
    Mashaly AH; Anwar R; Ebrahim MA; Eissa LA; El Shishtawy MM
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1503-1508. PubMed ID: 29936723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma.
    Zhang S; Liang X; Zheng X; Huang H; Chen X; Wu K; Wang B; Ma S
    Int J Clin Exp Pathol; 2014; 7(5):2079-90. PubMed ID: 24966916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The possible role of Dickkopf-1, Golgi protein- 73 and Midkine as predictors of hepatocarcinogenesis: a review and an Egyptian study.
    N Zekri AR; El Kassas M; Salam ESE; Hassan RM; Mohanad M; Gabr RM; M Lotfy M; Abdel-Zaher RAT; Bahnassy AA; Ahmed OS
    Sci Rep; 2020 Mar; 10(1):5156. PubMed ID: 32198440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multifunctional Lipid-Based Nanodevice for the Highly Specific Codelivery of Sorafenib and Midkine siRNA to Hepatic Cancer Cells.
    Younis MA; Khalil IA; Abd Elwakil MM; Harashima H
    Mol Pharm; 2019 Sep; 16(9):4031-4044. PubMed ID: 31403802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis.
    Wang Y; He D; Yang L; Wen B; Dai J; Zhang Q; Kang J; He W; Ding Q; He D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):458-65. PubMed ID: 26043685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of serum midkine level in diagnosis of hepatocellular carcinoma.
    Shaheen KY; Abdel-Mageed AI; Safwat E; AlBreedy AM
    Int J Hepatol; 2015; 2015():146389. PubMed ID: 25737783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression.
    Hu B; Yan X; Liu F; Zhu C; Zhou H; Chen Y; Liu J; Gu X; Ni R; Zhang T
    Pathol Oncol Res; 2016 Jul; 22(3):555-65. PubMed ID: 26715439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.